Rafael Molds Ltd

Guangdong Bawei Biotechnology Co, Ltd.(abbreviation: Bawei) was established in 2006. It was listed on the New Third Board in 2016 and landed in the capital market. It is a cosmetics brand customer integrating product planning, formula research and development, manufacturing, and efficacy testing. service provider. An innovative cosmetics technology enterprise with the core competitiveness of building full life cycle quality management; it has successively passed ISO9001, GMPC, ISO22716, ISO14001 and other system certifications, introduced domestic and foreign advanced production equipment and digital management systems, and invested more than 300 million to build the Baba Wei Innovation Center & Smart Factory will be officially put into operation in 2021, continuously promoting the lean production model and Industrialization 4.0. Bavi has been committed to the research and practice of biotechnology, beauty, health and personal care. It has 133 authorized patents, including 116 invention patents, providing professional and competitive overall solutions for brands in major channels from waist to head. solution. Bawei adheres to the mission of "making outstanding contributions to human health and beauty", and with the blessing of its own unique and reliable genes, it continues to promote the company's advanced research and development, authoritative testing, intelligent manufacturing, personalized customization, and capitalization. Operate the development of various major sectors.